首页 | 本学科首页   官方微博 | 高级检索  
检索        

安体维康诱导肝细胞凋亡实验研究及临床观察
引用本文:马建民,徐向田,胡顺晓,李玉兰.安体维康诱导肝细胞凋亡实验研究及临床观察[J].浙江中西医结合杂志,2002,12(4):209-210.
作者姓名:马建民  徐向田  胡顺晓  李玉兰
作者单位:1. 山东省临沂市医学高等专科学校,临沂,276002
2. 山东省临沂市河东区人民医院
3. 山东省临沂市交通职工医院
基金项目:国家科技部创新项目基金支助项目立项代码 0 10 2 62 13 70 0 15 5
摘    要:目的 :评价中药制剂安体维康 ( Antivirus Compound,ATVC)诱导人肝癌细胞凋亡的作用及临床疗效。方法 :采用 MTT(细胞毒 )实验培养人肝癌细胞株 BEL - 740 2细胞 ,加入不同浓度安体维康药液进行培养与对照组进行比较。临床给原发性肝癌 1 0例服用安体维康胶囊 3个月。结果 :安体维康能抑制人肝癌细胞株 BEL- 740 2细胞生长 ,有诱导肝细胞凋亡的作用。其作用强弱在一定程度上存在剂量和时间效应。服用安体维康的肝癌患者临床症状明显改善。结论 :安体维康可诱导人肝癌细胞调亡 ,对原发性肝癌有一定临床疗效

关 键 词:安体维康  细胞凋亡  人肝癌细胞株  肝癌
修稿时间:2001年11月9日

Experimental Study and Clinical Observation of Antivirus Compound in Inducing hepatic Apoptosis
Ma Jianming,Hu Shunxiao,Li Yulan.Experimental Study and Clinical Observation of Antivirus Compound in Inducing hepatic Apoptosis[J].Zhejiang Journal of Integrated Traditional Chinese and Western Medicine,2002,12(4):209-210.
Authors:Ma Jianming  Hu Shunxiao  Li Yulan
Institution:Ma Jianming,Hu Shunxiao,Li Yulan.Linxin Hospital of Shangdong Province,Linxin 276002
Abstract:Objective: To evaluate the effect and clinical efficacy of Antivirus Compound in inducing hepatic apoptosis.Methods:Human hepatic cells BEL 7402 was cultured and different concentration of Antivirus Compound was added into the culture media with the control group.Clinically,10 primary hepatic cancer cases were treated with Antivirus Compound for 3 months.Results: Antivirus Compound can inhibit the growth of hepatic cancer cells,inducing apoptosis.The cases had improved clinical conditions. Conclusion:Antivirus Compound was effective in treating primary hepatic cancer cases by induing apoptois.
Keywords:Antivirus Compound  Apoptosis  Hepatic cell  Hepatic cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号